Cerebrospinal fluid neurofilament light and tau protein as mortality biomarkers in parkinsonism
- 9 May 2019
- journal article
- research article
- Published by Wiley in Acta Neurologica Scandinavica
- Vol. 140 (2) , 147-156
Abstract
Background Mortality is increased in parkinsonian disorders; moderately in Parkinson's disease (PD) but markedly in atypical parkinsonian disorders (APD), including multiple system atrophy (MSA), progressive supranuclear palsy (PSP) and corticobasal degeneration (CBD). Still, there are no reliable quantitative biomarkers for mortality. The cerebrospinal fluid (CSF) neurodegeneration biomarkers neurofilament light chain (NF‐L), total tau (t‐tau) and the tau pathology marker phosphorylated tau (p‐tau) are related to mortality in other neurological disorders (e.g. amyotrophic lateral sclerosis, Alzheimer′s disease), but have not been investigated in this respect in parkinsonian disorders. Aims To investigate the CSF‐biomarkers′ (NF‐L, t‐tau and p‐tau) relationship to mortality in parkinsonian disorders. Methods Demographic, mortality and CSF‐data were collected from 68 PD and 83 APD patients. Survival analysis was conducted using Cox regression, with age at lumbar puncture, gender, diagnosis and levels of CSF‐biomarkers as predictors. Results NF‐L in CSF was associated with increased mortality in synucleinopathies (PD, MSA) [HR 3.698 (2.196‐6.228, 95% confidence interval (CI), p<0.001], in PSP [HR 2.767 (1.126‐6.802 95% CI), p=0.027], and in the entire cohort [HR 1.661 (1.082‐2.55, 95% CI), p=0.02]. T‐tau in CSF was associated with increased mortality in PSP [HR 9.587 (1.143‐80.418), p=0.037]. P‐tau in CSF was associated with decreased mortality in synucleinopathies [HR 0.196 (0.041‐0.929, 95% CI), p=0.040]. APD and tauopathies were associated with higher mortality [HR 8.798 (4.516‐17.14, 95% CI) and HR 3.040 (1.904‐4.854) respectively, p<0.001]. Conclusion NF‐L and tau protein in CSF might be useful for mortality prognosis in patients with parkinsonian disorders and should be investigated in larger studies.Keywords
Funding Information
- Torsten Söderbergs Stiftelse
This publication has 37 references indexed in Scilit:
- Cerebrospinal Fluid Tau Levels Predict Prognosis in Non-Inherited Frontotemporal DementiaNeurodegenerative Diseases, 2013
- The natural history of multiple system atrophy: a prospective European cohort studyThe Lancet Neurology, 2013
- CSF biomarkers predict a more malignant outcome in Alzheimer diseaseNeurology, 2010
- A consensus protocol for the standardization of cerebrospinal fluid collection and biobankingNeurology, 2009
- Second consensus statement on the diagnosis of multiple system atrophyNeurology, 2008
- CSF neurofilament light chain and tau differentiate multiple system atrophy from Parkinson's diseaseNeurobiology of Aging, 2007
- SIC Task Force appraisal of clinical diagnostic criteria for parkinsonian disordersMovement Disorders, 2003
- Natural history and survival of 14 patients with corticobasal degeneration confirmed at postmortem examinationJournal of Neurology, Neurosurgery & Psychiatry, 1998
- Increased cerebrospinal fluid levels of neurofilament protein in progressive supranuclear palsy and multiple‐system atrophy compared with Parkinson's diseaseMovement Disorders, 1998
- Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases.Journal of Neurology, Neurosurgery & Psychiatry, 1992